Infantile Hemangiomas Withdrawn Phase 2 Trials for Timolol (DB00373)

Also known as: Infantile Haemangiomas / Infantile Hemangioma / Infantile haemangioma

IndicationStatusPhase
DBCOND0053448 (Infantile Hemangiomas)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01408056Timolol Option for Ulcerated Hemangiomas (TOUCH Trial)Treatment